Cargando…

Proteomic analysis of non-small cell lung cancer tissue interstitial fluids

BACKGROUND: Non-small cell lung cancer (NSCLC) accounts for more than 80% of all lung cancers, and reliable biomarkers are desirable. The present investigation assesses our ability to identify tumor relevant proteins from NSCLC tissue interstitial fluid (TIF). METHODS: Paired TIF was collected from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shaomin, Wang, Rui, Zhang, Mingxin, Wang, Lina, Cheng, Shaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751644/ https://www.ncbi.nlm.nih.gov/pubmed/23914992 http://dx.doi.org/10.1186/1477-7819-11-173

Ejemplares similares

In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery
por: Zhang, Jian, et al.
Publicado: (2017)

Proteomic Analysis of Testicular Interstitial Fluid in Men with Azoospermia
por: Huang, I-Shen, et al.
Publicado: (2023)

Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma
por: Sun, Wei, et al.
Publicado: (2016)

Proteomics: Potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease
por: Wu, Yinlan, et al.
Publicado: (2023)

Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study
por: Majewski, Sebastian, et al.
Publicado: (2021)

Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report
por: XUE, XINYING, et al.
Publicado: (2013)

A New Method for Isolation of Interstitial Fluid from Human Solid Tumors Applied to Proteomic Analysis of Ovarian Carcinoma Tissue
por: Haslene-Hox, Hanne, et al.
Publicado: (2011)

Computational Modeling of Interstitial Fluid Pressure and Velocity in Non-small Cell Lung Cancer Brain Metastases Treated With Stereotactic Radiosurgery
por: Swinburne, Nathaniel, et al.
Publicado: (2020)

Integrative Proteomics and Tissue Microarray Profiling Indicate the Association between Overexpressed Serum Proteins and Non-Small Cell Lung Cancer
por: Liu, Yansheng, et al.
Publicado: (2012)

Feasibility research of non-invasive methods for interstitial fluid level measurement
por: Pockevicius, Vytautas, et al.
Publicado: (2017)

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
por: Kato, Motoyasu, et al.
Publicado: (2014)

Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor‐induced interstitial lung disease in patients with non‐small cell lung cancer
por: Murata, Daiki, et al.
Publicado: (2022)

Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis
por: Nakajima, Mio, et al.
Publicado: (2017)

Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer
por: Kim, Kyeong-Hyun, et al.
Publicado: (2013)

Interstitial lung disease in patients with non-small-cell lung cancer: causes, mechanisms and management
por: Camus, P
Publicado: (2004)

Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease
por: Kanai, Osamu, et al.
Publicado: (2018)

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
por: Kobayashi, Haruki, et al.
Publicado: (2018)

Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer
por: Bao, Minwei, et al.
Publicado: (2022)

Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer
por: Wang, Yanning, et al.
Publicado: (2022)

Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia
por: Ikeda, Satoshi, et al.
Publicado: (2021)

Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia
por: Hashimoto, Shingo, et al.
Publicado: (2022)

Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer
por: Kawata, Toshio, et al.
Publicado: (2019)

Characterization of tumour mutation burden in patients with non‐small cell lung cancer and interstitial lung disease
por: Kobayashi, Haruki, et al.
Publicado: (2019)

Treatment and relapse of interstitial lung disease in nivolumab‐treated patients with non–small cell lung cancer
por: Sata, Masafumi, et al.
Publicado: (2021)

Interstitial lung disease and wedge resection are poor prognostic factors for non-small cell lung cancer
por: Motono, Nozomu, et al.
Publicado: (2022)

Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes
por: Ito, Makoto, et al.
Publicado: (2023)

Newly diagnosed non‐small cell lung cancer with interstitial lung abnormality: Prevalence, characteristics, and prognosis
por: Zhu, Min, et al.
Publicado: (2023)

AN INQUIRY INTO THE STRUCTURAL CONDITIONS AFFECTING FLUID TRANSPORT IN THE INTERSTITIAL TISSUE OF THE SKIN
por: McMaster, Philip D.
Publicado: (1941)

Assessment of the interstitial fluid in the subcutaneous tissue of healthy adults using ultrasonography
por: Ueda-Iuchi, Terumi, et al.
Publicado: (2015)

Impact of pulmonary interstitial lesions on efficacy and prognosis of EGFR-TKI-treated advanced non-small cell lung cancers
por: Zhang, Xiang-Yan, et al.
Publicado: (2020)

The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis
por: Wang, Yanning, et al.
Publicado: (2020)

Proteomic Biomarkers for Acute Interstitial Lung Disease in Gefitinib-Treated Japanese Lung Cancer Patients
por: Nyberg, Fredrik, et al.
Publicado: (2011)

LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer
por: Zhou, Murong, et al.
Publicado: (2021)

Characteristics of non-small-cell lung cancer with interstitial pneumonia: variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia
por: Ogawa, Kazumasa, et al.
Publicado: (2020)

Pembrolizumab for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer and Preexisting Interstitial Lung Disease
por: Fujita, Tetsuo, et al.
Publicado: (2020)

Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non–small cell lung cancer
por: Saito, Yoshinobu, et al.
Publicado: (2021)

Impact of sarcopenia on chemotherapy‐triggered exacerbation of interstitial lung disease in patients with non‐small cell lung cancer
por: Kikuchi, Ryota, et al.
Publicado: (2021)

Clinical implication of interstitial lung abnormality in elderly patients with early‐stage non‐small cell lung cancer
por: Cho, Seong Woo, et al.
Publicado: (2022)

A nomogram for the prediction of the survival of patients with advanced non‐small cell lung cancer and interstitial lung disease
por: Xiu, Weigang, et al.
Publicado: (2023)

Endotoxin markers in bronchoalveolar lavage fluid of patients with interstitial lung diseases
por: Szponar, Bogumiła, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_10gftb05m6c17u3l0b8pkc8kse